|
S550
|
6505-01-472-2620
|
Thimerosal And Alcohol Solution |
Siemens Healthcare Diagnostics Inc.
|
|
Quote
|
|
S550
|
6505-01-472-2620
|
Thimerosal And Alcohol Solution |
Dade Behring Inc
|
|
Quote
|
|
S550
|
6505-01-472-2620
|
Thimerosal And Alcohol Solution |
Dade Behring Inc
|
|
Quote
|
|
S550
|
6505-01-472-2620
|
Thimerosal And Alcohol Solution |
Siemens Healthcare Diagnostics Inc.
|
|
Quote
|
|
S550
|
6505-01-472-2620
|
Thimerosal And Alcohol Solution |
Dade Behring Inc
|
|
Quote
|
|
S550
|
6505-01-472-2620
|
Thimerosal And Alcohol Solution |
Siemens Healthcare Diagnostics Inc.
|
|
Quote
|
|
S550
|
6505-01-472-2620
|
Thimerosal And Alcohol Solution |
Dade Behring Inc
|
|
Quote
|
|
S560
|
6505-01-472-2621
|
Thimerosal And Alcohol Solution |
Siemens Healthcare Diagnostics Inc.
|
|
Quote
|
|
S560
|
6505-01-472-2621
|
Thimerosal And Alcohol Solution |
Dade Behring Inc
|
|
Quote
|
|
S560
|
6505-01-472-2621
|
Thimerosal And Alcohol Solution |
Dade Behring Inc
|
|
Quote
|
|
S560
|
6505-01-472-2621
|
Thimerosal And Alcohol Solution |
Siemens Healthcare Diagnostics Inc.
|
|
Quote
|
|
S560
|
6505-01-472-2621
|
Thimerosal And Alcohol Solution |
Dade Behring Inc
|
|
Quote
|
|
S560
|
6505-01-472-2621
|
Thimerosal And Alcohol Solution |
Siemens Healthcare Diagnostics Inc.
|
|
Quote
|
|
S560
|
6505-01-472-2621
|
Thimerosal And Alcohol Solution |
Dade Behring Inc
|
|
Quote
|
|
99-1575
|
6505-01-472-3415
|
Methylphenidate Hydrochloride Ex |
Defense Logistics Agency
|
|
Quote
|
|
NDC60429-0539-01
|
6505-01-472-3415
|
Methylphenidate Hydrochloride Ex |
Golden State Medical Supply, Inc.
|
|
Quote
|
|
NDC00406-1445-01
|
6505-01-472-3415
|
Methylphenidate Hydrochloride Ex |
Mallinckrodt Inc
|
|
Quote
|
|
99-1575
|
6505-01-472-3415
|
Methylphenidate Hydrochloride Ex |
Defense Logistics Agency
|
|
Quote
|
|
NDC00406-1445-01
|
6505-01-472-3415
|
Methylphenidate Hydrochloride Ex |
Mallinckrodt Inc
|
|
Quote
|
|
99-1575
|
6505-01-472-3415
|
Methylphenidate Hydrochloride Ex |
Defense Logistics Agency
|
|
Quote
|
|
NDC00406-1445-01
|
6505-01-472-3415
|
Methylphenidate Hydrochloride Ex |
Mallinckrodt Inc
|
|
Quote
|
|
99-1408
|
6505-01-472-4531
|
Nf Sodium Carbonate |
Defense Logistics Agency
|
|
Quote
|
|
AC213500010
|
6505-01-472-4531
|
Nf Sodium Carbonate |
Fisher Scientific Company L.l.c.
|
|
Quote
|
|
00-0253
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Defense Logistics Agency
|
|
Quote
|
|
NDC00904-0478-60
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00536-3504-01
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Watson Pharma Inc
|
|
Quote
|
|
0536-3504-01
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Watson Pharma Inc
|
|
Quote
|
|
NDC00904-0478-60
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
MAALOX PLUS
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
MAALOX PLUS TABLETS
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00067-0339-50
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00536-3035-01
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Watson Pharma Inc
|
|
Quote
|
|
NDC00536-3035-01
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC00536-3035-01
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Cardinal Health 200, Llc
|
|
Quote
|
|
003-0350
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Rugby Laboratories Inc
|
|
Quote
|
|
ALMACONE
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Rugby Laboratories Inc
|
|
Quote
|
|
NDC00536-1011-01
|
6505-01-473-1770
|
Simethicone T Magnesium Aluminum |
Major Pharmaceuticals Inc
|
|
Quote
|
|
00-0151
|
6505-01-473-4690
|
Granisetron Hydrochloride Tablet |
Defense Logistics Agency
|
|
Quote
|
|
KYTRIL
|
6505-01-473-4690
|
Granisetron Hydrochloride Tablet |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0238-08
|
6505-01-473-4690
|
Granisetron Hydrochloride Tablet |
Roche Laboratories Inc.
|
|
Quote
|
|
00-0294
|
6505-01-473-7775
|
Pseudoephedrine Hydrochloride Ta |
Defense Logistics Agency
|
|
Quote
|
|
NDC00904-5125-59
|
6505-01-473-7775
|
Pseudoephedrine Hydrochloride Ta |
The Harvard Drug Group L.l.c.,
|
|
Quote
|
|
NDC00472-0735-14
|
6505-01-473-8008
|
Usp Miconazole Nitrate Cream |
Actavis Elizabeth Llc
|
|
Quote
|
|
00-0304
|
6505-01-473-8008
|
Usp Miconazole Nitrate Cream |
Defense Logistics Agency
|
|
Quote
|
|
NDC51672-2001-01
|
6505-01-473-8008
|
Usp Miconazole Nitrate Cream |
Taro Pharmaceuticals Inc
|
|
Quote
|
|
1100133
|
6505-01-474-3709
|
Usp Rabies Immune Globulin |
Sanofi Pasteur Inc.
|
|
Quote
|
|
DIN 02237328
|
6505-01-474-3709
|
Usp Rabies Immune Globulin |
Sanofi Pasteur Inc.
|
|
Quote
|
|
GAMMAR PIV
|
6505-01-474-4995
|
For Injection Immune Globulin |
Centeon Llc
|
|
Quote
|
|
NDC00053-7486-05
|
6505-01-474-4995
|
For Injection Immune Globulin |
Centeon Llc
|
|
Quote
|
|
NDC00053-7486-05
|
6505-01-474-4995
|
For Injection Immune Globulin |
Centeon Llc
|
|
Quote
|
|
GAMMAR PIV
|
6505-01-474-4995
|
For Injection Immune Globulin |
Centeon Llc
|
|
Quote
|
|
NDC00053-7486-05
|
6505-01-474-4995
|
For Injection Immune Globulin |
Centeon Llc
|
|
Quote
|
|
GAMMAR PIV
|
6505-01-474-4995
|
For Injection Immune Globulin |
Centeon Llc
|
|
Quote
|
|
NDC00053-7486-05
|
6505-01-474-4995
|
For Injection Immune Globulin |
Centeon Llc
|
|
Quote
|
|
00-0351
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00641-6006-10
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
00-0351
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00641-6006-10
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
00-0351
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00641-6006-10
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
00-0351
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00641-6006-10
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
00-0351
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00641-6006-10
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
00-0351
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00641-6006-10
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
00-0351
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00641-6006-10
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC10019-0250-20
|
6505-01-474-5440
|
Usp Atropine Sulfate Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
00-0353
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3159-20
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3159-20
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3159-20
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0353
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3159-20
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0353
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3159-20
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0353
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3159-20
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0353
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3159-20
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0353
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3159-20
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0353
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3159-20
|
6505-01-474-5599
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0355
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3160-20
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3160-20
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3160-20
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0355
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3160-20
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0355
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3160-20
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0355
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3160-20
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0355
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3160-20
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0355
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3160-20
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0355
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
AVANDIA
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3160-20
|
6505-01-474-5604
|
Rosiglitazone Maleate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0329
|
6505-01-474-7613
|
Diagnostic Barium Sulfate |
Defense Logistics Agency
|
|
Quote
|
|
902102
|
6505-01-474-7613
|
Diagnostic Barium Sulfate |
Bracco Diagnostics Inc
|
|
Quote
|
|
LIQUID ENTEROVU
|
6505-01-474-8604
|
Usp Barium Sulfate Suspension |
E-z-em Inc
|
|
Quote
|
|
00-0520
|
6505-01-474-8604
|
Usp Barium Sulfate Suspension |
Defense Logistics Agency
|
|
Quote
|
|
L140
|
6505-01-474-8604
|
Usp Barium Sulfate Suspension |
E-z-em Inc
|
|
Quote
|
|
NDC 32909-140-06
|
6505-01-474-8604
|
Usp Barium Sulfate Suspension |
E-z-em Inc
|
|
Quote
|
|
NDC00074-1698-10
|
6505-01-475-2156
|
Usp Bretylium Tosylate Injection |
Abbott Laboratories
|
|
Quote
|
|
02-2393
|
6505-01-475-2156
|
Usp Bretylium Tosylate Injection |
Defense Logistics Agency
|
|
Quote
|
|
ANSYR
|
6505-01-475-2156
|
Usp Bretylium Tosylate Injection |
Abbott Laboratories
|
|
Quote
|
|
ANSYR SYRINGE
|
6505-01-475-2156
|
Usp Bretylium Tosylate Injection |
Abbott Laboratories
|
|
Quote
|
|
NDC00517-8810-01
|
6505-01-475-2156
|
Usp Bretylium Tosylate Injection |
Luitpold Pharmaceuticals Inc
|
|
Quote
|
|
RECOMBIVAX HB
|
6505-01-475-3038
|
Inacti Hepatitis B Virus Vaccine |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
00-0400
|
6505-01-475-3038
|
Inacti Hepatitis B Virus Vaccine |
Defense Logistics Agency
|
|
Quote
|
|
NDC00006-4981-00
|
6505-01-475-3038
|
Inacti Hepatitis B Virus Vaccine |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
8547007-10LT
|
6505-01-475-8718
|
Micro Pak |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
8546929-1LT
|
6505-01-475-8719
|
Clenz |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
8547049-10LT
|
6505-01-475-8720
|
Onyx Pak |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00-0457
|
6505-01-476-5543
|
Usp Tolbutamide Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC00378-0215-01
|
6505-01-476-5543
|
Usp Tolbutamide Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00378-0215-01
|
6505-01-476-5543
|
Usp Tolbutamide Tablets |
Cardinal Health 100 Inc
|
|
Quote
|
|
CILOXAN
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Alcon Laboratories, Inc.
|
|
Quote
|
|
00-0455
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Defense Logistics Agency
|
|
Quote
|
|
NDC00065-0654-35
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0654-35
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Veterans Health
|
|
Quote
|
|
CILOXAN
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Alcon Laboratories, Inc.
|
|
Quote
|
|
00-0455
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Defense Logistics Agency
|
|
Quote
|
|
NDC00065-0654-35
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0654-35
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Veterans Health
|
|
Quote
|
|
CILOXAN
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Alcon Laboratories, Inc.
|
|
Quote
|
|
00-0455
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Defense Logistics Agency
|
|
Quote
|
|
NDC00065-0654-35
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0654-35
|
6505-01-476-8686
|
Ciprofloxacin Hydrochloride Opht |
Veterans Health
|
|
Quote
|
|
00575620030
|
6505-01-476-8874
|
Usp Diazoxide Oral Suspension |
Baker Norton Pharmaceutical Inc
|
|
Quote
|
|
PROGLYCEM 50MG/ML 1X30ML
|
6505-01-476-8874
|
Usp Diazoxide Oral Suspension |
Baker Norton Pharmaceutical Inc
|
|
Quote
|
|
00575620030
|
6505-01-476-8874
|
Usp Diazoxide Oral Suspension |
Baker Norton Pharmaceutical Inc
|
|
Quote
|
|
PROGLYCEM 50MG/ML 1X30ML
|
6505-01-476-8874
|
Usp Diazoxide Oral Suspension |
Baker Norton Pharmaceutical Inc
|
|
Quote
|
|
00575620030
|
6505-01-476-8874
|
Usp Diazoxide Oral Suspension |
Baker Norton Pharmaceutical Inc
|
|
Quote
|
|
PROGLYCEM 50MG/ML 1X30ML
|
6505-01-476-8874
|
Usp Diazoxide Oral Suspension |
Baker Norton Pharmaceutical Inc
|
|
Quote
|
|
NDC00832-1015-50
|
6505-01-476-9917
|
Amantadine Hydrochloride Capsule |
Donovan and Sons Inc
|
|
Quote
|
|
NDC42291-0125-50
|
6505-01-476-9917
|
Amantadine Hydrochloride Capsule |
Avkare, Inc.
|
|
Quote
|
|
6505NCM000207
|
6505-01-477-6768
|
Recombinant For Inject Retaplase |
Defense Medical Standardization
|
|
Quote
|
|
00-0440
|
6505-01-477-6768
|
Recombinant For Inject Retaplase |
Defense Logistics Agency
|
|
Quote
|
|
NDC24477-0041-02
|
6505-01-477-6768
|
Recombinant For Inject Retaplase |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC24477-0041-02
|
6505-01-477-6768
|
Recombinant For Inject Retaplase |
Ekr Therapeutics Incorporated
|
|
Quote
|
|
RETAVASE
|
6505-01-477-6768
|
Recombinant For Inject Retaplase |
Ekr Therapeutics Incorporated
|
|
Quote
|
|
NDC67286-0040-01
|
6505-01-477-6768
|
Recombinant For Inject Retaplase |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC67286-0040-01
|
6505-01-477-6768
|
Recombinant For Inject Retaplase |
Ekr Therapeutics Incorporated
|
|
Quote
|
